Agranulocytosis Induced by Tamoxifen in a Breast Cancer Patient
Conclusion: Agranulocytosis is a very rare adverse event of tamoxifen.Breast Care
Source: Breast Care - Category: Cancer & Oncology Source Type: research
More News: Arimidex | Breast Cancer | Cancer | Cancer & Oncology | Hematology | Men | Menopause | Ovarian Cancer | Ovaries | Tamoxifen